Market Cap 257.77M
Revenue (ttm) 20.46M
Net Income (ttm) -30.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -146.82%
Debt to Equity Ratio 0.07
Volume 270,900
Avg Vol 346,164
Day's Range N/A - N/A
Shares Out 105.21M
Stochastic %K 98%
Beta 0.23
Analysts Strong Sell
Price Target $8.88

Company Profile

ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company's products pipeline includes AX-0810 for cholestatic diseases targeting Na-taurocholate cotransporting polypeptide (NTCP); and AX-1412 for cardiovascular diseases (CVDs) targeting Beta-1,4-galactosyltransferase 1 (B4GALT1). It also develops various other early-stage research programs, including AX-1005 for undisclosed targets in CVDs; AX-2402, which focuses on Re...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 88 166 7000
Address:
Zernikedreef 9, Leiden, Netherlands
Universaal
Universaal Oct. 4 at 1:31 PM
$PRQR if it gets me $10 after holding 6 long years then I’m honored 😊
0 · Reply
dirkfrank
dirkfrank Oct. 3 at 8:22 PM
0 · Reply
biochirp
biochirp Oct. 3 at 8:18 PM
$PRQR any good news from Lily programs and this explodes
0 · Reply
ehpats
ehpats Oct. 3 at 6:44 PM
$PRQR good day here. Nice to see on a Friday
0 · Reply
ehpats
ehpats Oct. 1 at 7:39 PM
$PRQR we are officially in Q4 now so we could get a data readout anytime over the next 90 days. Good data, which I expect to be the case, could significantly increase the value of this enterprise. 🤞
2 · Reply
ehpats
ehpats Oct. 1 at 7:27 PM
$PRQR added another 700 here today. I felt like this might be low for October so might as well add on day 1.
0 · Reply
LeftyT
LeftyT Oct. 1 at 4:01 PM
$PRQR Added another 500 sh atm and paid 2.1494 for them. I Get them now while they are cheaper than what Mr Van Herk paid for his buys in September. :)
1 · Reply
LeftyT
LeftyT Oct. 1 at 3:40 PM
$PRQR From the new 13D filing: Mr Van Herk, via his VHI entity, added 1,055,000 shares in September at an average price of $2.18/shares. That brought his total up to 14,329,690 shares. That's a healthy increase in a major position. Interesting move.
1 · Reply
highnihilism
highnihilism Oct. 1 at 10:03 AM
$CNXN PC Connection Trade Count: 20 | Total $: 2.2 K | 1.41 × 90-Day Avg $: 1.5 K | Call $: 2.2 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PRQR Proqr Therapeutics Trade Count: 11 | Total $: 2.2 K | 1.17 × 90-Day Avg $: 1.8 K | Call $: 2.2 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $YBIT Tidal Trust II Yieldmax Bitcoin Option Income Strategy ETF Trade Count: 8 | Total $: 2.4 K | 0.97 × 90-Day Avg $: 2.5 K | Call $: 2.2 K | Put $: 250 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $TRX TRX Gold Trade Count: 21 | Total $: 2.2 K | 1.94 × 90-Day Avg $: 1.1 K | Call $: 2.2 K | Put $: 0 | % Single-Leg: 90% | % Multi-Leg: 10% | % Contingent: –
0 · Reply
johnnygogogo
johnnygogogo Sep. 30 at 9:45 PM
$PRQR Van Hercules still buying. https://www.sec.gov/Archives/edgar/data/1612940/000110465925095007/xslSCHEDULE_13D_X01/primary_doc.xml
1 · Reply
Latest News on PRQR
ProQR Announces Upcoming Presentation at RNA Editing Summit

Jul 28, 2025, 8:00 AM EDT - 2 months ago

ProQR Announces Upcoming Presentation at RNA Editing Summit


ProQR Announces Year End 2024 Operating and Financial Results

Mar 13, 2025, 7:00 AM EDT - 7 months ago

ProQR Announces Year End 2024 Operating and Financial Results


ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

Dec 10, 2024, 8:00 AM EST - 10 months ago

ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist


ProQR Announces Year End 2023 Operating and Financial Results

Mar 13, 2024, 7:00 AM EDT - 1 year ago

ProQR Announces Year End 2023 Operating and Financial Results


ProQR: Too Many Failures For Its RNA Technology

Jul 9, 2023, 6:53 AM EDT - 2 years ago

ProQR: Too Many Failures For Its RNA Technology


ProQR Announces Upcoming Investor Conferences in April and May

Apr 20, 2023, 8:00 AM EDT - 2 years ago

ProQR Announces Upcoming Investor Conferences in April and May


ProQR's stock jumps on expanded RNA deal with Lilly

Dec 22, 2022, 9:12 AM EST - 3 years ago

ProQR's stock jumps on expanded RNA deal with Lilly

LLY


Lilly and ProQR to Expand RNA Editing Collaboration

Dec 22, 2022, 6:00 AM EST - 3 years ago

Lilly and ProQR to Expand RNA Editing Collaboration

LLY


ProQR to Participate in the Kempen Life Sciences Conference

Apr 19, 2022, 4:30 PM EDT - 3 years ago

ProQR to Participate in the Kempen Life Sciences Conference


Universaal
Universaal Oct. 4 at 1:31 PM
$PRQR if it gets me $10 after holding 6 long years then I’m honored 😊
0 · Reply
dirkfrank
dirkfrank Oct. 3 at 8:22 PM
0 · Reply
biochirp
biochirp Oct. 3 at 8:18 PM
$PRQR any good news from Lily programs and this explodes
0 · Reply
ehpats
ehpats Oct. 3 at 6:44 PM
$PRQR good day here. Nice to see on a Friday
0 · Reply
ehpats
ehpats Oct. 1 at 7:39 PM
$PRQR we are officially in Q4 now so we could get a data readout anytime over the next 90 days. Good data, which I expect to be the case, could significantly increase the value of this enterprise. 🤞
2 · Reply
ehpats
ehpats Oct. 1 at 7:27 PM
$PRQR added another 700 here today. I felt like this might be low for October so might as well add on day 1.
0 · Reply
LeftyT
LeftyT Oct. 1 at 4:01 PM
$PRQR Added another 500 sh atm and paid 2.1494 for them. I Get them now while they are cheaper than what Mr Van Herk paid for his buys in September. :)
1 · Reply
LeftyT
LeftyT Oct. 1 at 3:40 PM
$PRQR From the new 13D filing: Mr Van Herk, via his VHI entity, added 1,055,000 shares in September at an average price of $2.18/shares. That brought his total up to 14,329,690 shares. That's a healthy increase in a major position. Interesting move.
1 · Reply
highnihilism
highnihilism Oct. 1 at 10:03 AM
$CNXN PC Connection Trade Count: 20 | Total $: 2.2 K | 1.41 × 90-Day Avg $: 1.5 K | Call $: 2.2 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PRQR Proqr Therapeutics Trade Count: 11 | Total $: 2.2 K | 1.17 × 90-Day Avg $: 1.8 K | Call $: 2.2 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $YBIT Tidal Trust II Yieldmax Bitcoin Option Income Strategy ETF Trade Count: 8 | Total $: 2.4 K | 0.97 × 90-Day Avg $: 2.5 K | Call $: 2.2 K | Put $: 250 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $TRX TRX Gold Trade Count: 21 | Total $: 2.2 K | 1.94 × 90-Day Avg $: 1.1 K | Call $: 2.2 K | Put $: 0 | % Single-Leg: 90% | % Multi-Leg: 10% | % Contingent: –
0 · Reply
johnnygogogo
johnnygogogo Sep. 30 at 9:45 PM
$PRQR Van Hercules still buying. https://www.sec.gov/Archives/edgar/data/1612940/000110465925095007/xslSCHEDULE_13D_X01/primary_doc.xml
1 · Reply
dirkfrank
dirkfrank Sep. 30 at 6:14 PM
$PRQR target price $14. But when? 2035?
2 · Reply
Breck100
Breck100 Sep. 29 at 9:34 PM
$PRQR Source: Raymond James
0 · Reply
justfacts1
justfacts1 Sep. 29 at 4:12 PM
$PRQR The outlook for ProQR is heavily tied to its clinical development milestones. Management anticipates up to four clinical trial data readouts in 2025 and 2026, with initial data for the lead AX-0810 program expected in Q4 2025. These readouts are considered key value drivers that could significantly re-rate the company's valuation, provided the data is positive and the company meets its clinical and partnership milestones. The ongoing collaboration with Eli Lilly also offers significant optionality, including a potential $50 million opt-in payment for an additional five targets, expanding the partnership to a total of 15 targets.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 3:07 PM
$PRQR Really good write-up that perfectly summarizes PRQR's present situation. So if you want to bring your PRQR knowledge up to date or just discover PRQR, this is required reading. https://beyondspx.com/quote/PRQR/analysis/proqr-therapeutics-axiomer-s-clinical-dawn-and-the-quest-for-transformative-rna-therapies-nasdaq-prqr
0 · Reply
justfacts1
justfacts1 Sep. 28 at 8:29 PM
$PRQR when will PRQR up list on nasdaq ?
1 · Reply
johnnygogogo
johnnygogogo Sep. 26 at 10:41 PM
$PRQR - more like $LLY fishing in its bathtub of fishies whenever they feel like it @dirkfrank
0 · Reply
dirkfrank
dirkfrank Sep. 26 at 8:24 PM
$PRQR trying to get $LLY interested
1 · Reply
CEM97
CEM97 Sep. 26 at 7:32 PM
$IMRX here is a stock that had a similar offering than IMRX. $PRQR it was priced at 3.50 and dropped all the way to $1.12 afterwards
1 · Reply
dirkfrank
dirkfrank Sep. 25 at 4:26 PM
$PRQR ouch
1 · Reply
Universaal
Universaal Sep. 25 at 1:19 AM
$PRQR crickets here awful 😞 investment ever
0 · Reply
Universaal
Universaal Sep. 20 at 7:02 PM
$PRQR is it worth waiting and adding here, cuz current administration not interested in gene 🧬 therapies new FDA is totally different
1 · Reply
Universaal
Universaal Sep. 19 at 11:20 PM
$MREO I want to buy below $1 this europa trash this is another trash $PRQR from europa
0 · Reply